Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Adamis Pharmaceuticl (ADMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 167,723
  • Shares Outstanding, K 31,350
  • Annual Sales, $ 6,470 K
  • Annual Income, $ -19,440 K
  • 36-Month Beta 0.02
  • Price/Sales 25.42
  • Price/Cash Flow 0.00
  • Price/Book 4.28

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.41 +21.32%
on 10/13/17
5.75 -6.96%
on 10/20/17
+0.15 (+2.88%)
since 09/20/17
3-Month
4.20 +27.38%
on 08/03/17
5.75 -6.96%
on 10/20/17
+0.70 (+15.05%)
since 07/20/17
52-Week
2.40 +122.92%
on 10/27/16
6.45 -17.05%
on 06/16/17
+2.53 (+89.72%)
since 10/20/16

Most Recent Stories

More News
Stock Performance Review on Drug Delivery Industry -- Adamis Pharma, Alkermes, PetMed Express, and Valeant Pharma

If you want a Stock Review on ADMP, ALKS, PETS, or VRX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Wednesday, the NASDAQ Composite ended the...

PETS : 36.74 (+2.43%)
ADMP : 5.35 (+1.90%)
ALKS : 50.58 (+0.04%)
VRX : 12.13 (-2.80%)
Technical Snapshots for these Drug Delivery Stocks -- Delcath Systems, Valeant Pharma, PetMed Express, and Adamis Pharma

If you want a Stock Review on DCTH, VRX, PETS, or ADMP then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. The market for Drug Delivery technology...

VRX.TO : 15.33 (-1.41%)
PETS : 36.74 (+2.43%)
ADMP : 5.35 (+1.90%)
DCTH : 0.0400 (unch)
VRX : 12.13 (-2.80%)
Why Have Mylan's (MYL) Shares Lost 19.4% So Far This Year?

Shares of Mylan N.V. (MYL) have lost almost 19.4% in the year so far given the competitive pressure.

MYL : 38.51 (+0.57%)
ADMP : 5.35 (+1.90%)
NVS : 85.74 (-0.49%)
GSK : 40.84 (-0.63%)
Today's Research Reports on Stocks to Watch: Adamis Pharmaceuticals and Mylan

NEW YORK, NY / ACCESSWIRE / August 14, 2017 / While shares of Mylan continued to suffer last Friday, competitor Adamis Pharmaceuticals saw gains. Adamis has an Epinephrine injection that is a generic...

MYL : 38.51 (+0.57%)
ADMP : 5.35 (+1.90%)
Technical Reports on Drug Delivery Equities -- PetMed Express, Adamis Pharma, Delcath Systems, and Alkermes

If you want a Stock Review on PETS, ADMP, DCTH or ALKS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Today's research on DailyStockTracker.com...

PETS : 36.74 (+2.43%)
ADMP : 5.35 (+1.90%)
DCTH : 0.0400 (unch)
ALKS : 50.58 (+0.04%)
Business Highlights

___

YHOO : 123.47 (unch)
ADMP : 5.35 (+1.90%)
AMZN : 982.91 (-0.38%)
WFM : 42.00 (+0.02%)
Adamis Gets FDA Nod for Generic Version of Mylan's EpiPen

Shares of Adamis Pharmaceuticals Corporation (ADMP) soared more than 50% after the FDA approved the company's Epinephrine injection, USP, (0.3 mg Pre-filled single dose syringe) which is the generic version...

MYL : 38.51 (+0.57%)
CVS : 76.49 (+2.49%)
ADMP : 5.35 (+1.90%)
IPXL : 21.25 (+1.19%)
Biotech Industry Showing Signs of a Revival in 2017: Today's Research on Adamis Pharmaceuticals and Arena Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / June 16, 2017 / The Biotech Industry has continued to outperform the broader markets till now in 2017. Biotech companies appear to be benefiting from a speedier FDA approval...

ADMP : 5.35 (+1.90%)
ARNA : 27.28 (-0.11%)
XBI : 85.62 (-0.11%)
FDA approves new, cheaper rival to EpiPen allergy shot

TRENTON, N.J. (AP) — U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed.

ADMP : 5.35 (+1.90%)
Research Reports Coverage on Drug Delivery Stocks -- Valeant Pharma, Delcath Systems, Alkermes, and Adamis Pharma

This morning, Stock-Callers.com takes a closer look at Valeant Pharmaceuticals International Inc. (NYSE: VRX), Delcath Systems Inc. (NASDAQ: DCTH), Alkermes PLC (NASDAQ: ALKS), and Adamis Pharmaceuticals...

VRX.TO : 15.33 (-1.41%)
ADMP : 5.35 (+1.90%)
DCTH : 0.0400 (unch)
VRX : 12.13 (-2.80%)
ALKS : 50.58 (+0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned...

See More

Support & Resistance

2nd Resistance Point 5.98
1st Resistance Point 5.67
Last Price 5.35
1st Support Level 5.12
2nd Support Level 4.88

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart